Table I.
Clinicopathological characteristics of the 11 cases.
| Characteristics | No. |
|---|---|
| Age (years) | |
| <50 | 5 |
| ≥50 | 6 |
| Origin | |
| Uterus | 10 |
| Retroperitoneum | 1 |
| Histological type | |
| Leiomyosarcoma | 6 |
| Adenosarcoma | 3 |
| Undifferentiated endometrial sarcoma | 2 |
| Stage (FIGO 1988) | |
| I | 4 |
| II | 0 |
| III | 1 |
| IV | 5 |
| Other | 1 |
| Type of disease | |
| Progressive | 6 |
| Recurrent | 5 |
| Initial treatment | |
| Surgery | 11 |
| Chemotherapy | 0 |
| Type of surgery | |
| Hysterectomy + BSO (USO) | 7 |
| Other | 4 |
| Chemotherapy prior to IAPa | |
| None | 9 |
| CYVADICb | 1 |
| DOC + GEM | 1 |
a
Ifosfamide, adriamycin and cisplatin.
b
Cyclophosphamide, vincristine, adriamycin and dacarbazine.
FIGO, International Federation of Gynecology and Obstetrics; BSO, bilateral salpingo-oophorectomy; USO, unilateral salpingo-oophorectomy; DOC, docetaxel; GEM, gemcitabine.